•  

     

    NEWS

    The most relevant news about our Group, in Argentina and around the world.

Argentinean foot-and-mouth vaccine to be manufactured in China

Yangling JINHAI Biotechnology Co recently received “Good Manufacturing Practices” certifications from the Ministry of Agriculture of China, and obtained the necessary licenses to begin producing and marketing the FMD vaccine for pigs and pigs. Cattle. This makes Biogenesis Bagó the first foreign laboratory to produce in China.

“It is a huge achievement for the country to be able to export biotechnology and knowledge to the world’s largest market for foot-and-mouth disease vaccine. In addition, the agreement is an example of what cooperation between companies developing technology and innovation can achieve together to contribute to better nutrition, “said Hugo Sigman, shareholder of Biogénesis Bagó and CEO of the Insud Group.

China owns half of the world’s pig population (700 million) and twice Argentina’s cattle stock (110 million), with growing domestic market demand and still unable to solve certain diseases, such as foot-and-mouth disease, that limit Meat and milk production.

The JINHAI plant is located in Yangling City, Shaanxi Province, in the center of the Asian country, 70 kilometers from Xian City, China’s first imperial capital. It is one of the most modern industrial developments in the world and has the latest technology in cell culture production, antigen purification and vaccine formulation. It emerged as a result of a joint venture between Biogenesis Bagó and the Chinese laboratory Hile Biotecnology Co, a private company that produces high technology vaccines for poultry and pigs.

The new Biogenesis Bagó plant involved an investment of approximately 60 million dollars and will have a production capacity of 400 million doses per year. As part of the technology transfer process, the company trained over the past four years a large part of the plant’s current operating staff.

The president of the Nation Mauricio Macri at the closing of the Forum of Business and Investment Argentina – China 2017 held in Beijing stressed that “the country has much to contribute to China in terms of food security and technology developments.”

(Español) Ver nota completa

Top Story

News

Algunas aclaraciones sobre la vacuna | Hugo Sigman

Por Hugo Sigman En momentos en que la segunda ola de Covid se cobra más y más muertos, con muchas familias perdiendo a sus seres queridos y el sistema de salud muy estresado, la intoxicación de noticias falsas sólo contribuye … Continue reading

+

Latest News

News Mabxience

Hugo Sigman, sobre la vacuna de AstraZeneca: “Confiamos en que las pruebas serán exitosas”

+

News Grupo Insud Mundo Sano

El futuro de la pandemia visto por la bioquímica Silvia Gold: “Mucho de lo que aprendimos con dengue, creemos que es lo que hay que hacer con COVID-19″

+

News Grupo Insud

Hugo Sigman: “El único negocio que tengo con el Estado representa el 1,5% de mi facturación”

+

News Top Story Grupo Insud

Silvia Gold: “Las vacunas que más esperanza nos generan son las de vector viral”

+

News Top Story Mabxience

mAbxience: cómo es el laboratorio argentino que va a producir la vacuna de la Universidad de Oxford y AstraZeneca para América Latina

+

News Inmunova Top Story

ANMAT aprobó estudio clínico en humanos para el suero anti-Covid-19

+

News Inmunova

Una revista de The Lancet publicó el estudio sobre suero equino contra el coronavirus

+

News Uncategorized

FRESA, el primer proyecto de Grupo Insud en el sector de las energías limpias

+